Clinical Data, Inc. Files Shelf Registration Statement

NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) today announced that the Company has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). The registration statement would permit Clinical Data to offer and sell up to $200 million of its common stock, preferred stock, debt securities or any combination of these, from time to time, subject to market conditions and the Company’s capital needs. The terms of any potential future offering would be established at the time of the offering.